All Articles

With $14M from Khosla Ventures, AI startup Nara Health challenges the status quo with alternative plans, promising radical cost savings for employers.

A new global day of giving aims to fuel Dolly Parton's Imagination Library, revealing a powerful philanthropic model that relies on local action for global impact.

Miral's massive investment isn't just about new rides. It's a calculated move in a regional race for tourism dominance. What does this mean for Abu Dhabi?

As AI moves from hype to production, investors are betting billions on the unglamorous but critical infrastructure that makes it all work. Here's why.

Vantage secures a massive credit line to build data centers at breakneck speed. Here's how it's shaping the high-stakes race to power our AI future.

Watsco's acquisition of The Granite Group isn't just about market share; it's a strategic fusion of legacy, scale, and next-generation technology.

A cancer diagnostics firm is acquiring a robotics company. A new $2.5M loan shows how serious the gamble is, revealing a story of high risk and high-tech ambition.

The Wall Street veteran outlines three "catastrophic" policy moves that he argues broke public trust and created our economic crisis—and why he sees salvation in a digital asset.

Drift's Twilight fragrance isn't just a new product. It's a savvy play in the $340B licensing market, bottling fandom to redefine the premium scent space.

Milliman MedInsight is embedding AI directly into analytics workflows, but its strategy isn't about chasing buzzwords. It's a calculated move to build trust.

New envoys from Japan, Estonia, and Nigeria are more than a formality. They signal Canada's pivot to tech alliances for supply chains and cybersecurity.

A small biotech assembles top experts to guide a promising, Sanofi-licensed drug through trials, betting it can solve a stubborn cardiovascular challenge.

Vensure Employer Solutions’ high-profile hire of Jennifer Robinson isn't just a new face; it's a strategic bet on integrating advanced risk tech into HR.

From web novel to global phenomenon, one Chinese IP is not just topping charts—it's building a new blueprint for cultural franchises. Here's the strategy.

With 16 OEM partnerships, Force Marketing is building a new digital backbone for dealerships, replacing vendor chaos with a unified, AI-driven network.

Chamberlain University brings back Jason Dunne as CAO to lead a bold expansion. His mission: scale up nursing education to combat the national workforce crisis.

New research reveals a startling disconnect between marketing and IT leaders on AI leadership, creating a governance chasm that puts brand reputation and innovation at risk.

eToro's user base is booming, but its investors are placing smaller bets. This paradox, driven by a 70% plunge in crypto trade size, signals a profound shift.

With a $1M funding round and a stunning 4,000-store rollout, Wizard Wellness is rewriting the startup playbook with its 'skincare for your nose' concept.

With impressive Phase 2 data, Revelyx Bio's ready-to-use recombinant toxin YY003 signals a major technological and practical shift for the aesthetics industry.